BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23718539)

  • 21. Risk factors and therapy for isolated central nervous system relapse of pediatric acute myeloid leukemia.
    Johnston DL; Alonzo TA; Gerbing RB; Lange BJ; Woods WG
    J Clin Oncol; 2005 Dec; 23(36):9172-8. PubMed ID: 16361619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma.
    Kyrtsonis MC; Vassilakopoulos TP; Kafasi N; Sachanas S; Tzenou T; Papadogiannis A; Galanis Z; Kalpadakis C; Dimou M; Kyriakou E; Angelopoulou MK; Dimopoulou MN; Siakantaris MP; Dimitriadou EM; Kokoris SI; Panayiotidis P; Pangalis GA
    Br J Haematol; 2007 May; 137(3):240-3. PubMed ID: 17408464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Adult acute lymphoblastic leukemia with central nervous system involvement: an overview].
    Thomas X; Pavan L; Le QH
    Bull Cancer; 2008; 95(7):707-15. PubMed ID: 18755650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Normalization of free light chain kappa/lambda ratio is a robust prognostic indicator of favorable outcome in patients with multiple myeloma.
    Iwama K; Chihara D; Tsuda K; Ugai T; Sugihara H; Nishida Y; Yamakura M; Takeuchi M; Matsue K
    Eur J Haematol; 2013 Feb; 90(2):134-41. PubMed ID: 23210517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrospective study of prognostic factors in non-Hodgkin lymphoma secondarily involving the central nervous system.
    Jahnke K; Thiel E; Martus P; Schwartz S; Korfel A
    Ann Hematol; 2006 Jan; 85(1):45-50. PubMed ID: 16132909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system.
    Gill P; Litzow M; Buckner J; Arndt C; Moynihan T; Christianson T; Ansell S; Galanis E
    Cancer; 2008 Apr; 112(8):1805-11. PubMed ID: 18300237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myelomatous Involvement of the Central Nervous System.
    Paludo J; Painuly U; Kumar S; Gonsalves WI; Rajkumar V; Buadi F; Lacy MQ; Dispenzieri A; Kyle RA; Mauermann ML; McCurdy A; Dingli D; Go RS; Hayman SR; Leung N; Lust JA; Lin Y; Gertz MA; Kapoor P
    Clin Lymphoma Myeloma Leuk; 2016 Nov; 16(11):644-654. PubMed ID: 27624224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The utility of performing the initial lumbar puncture on day 8 in remission induction therapy for childhood acute lymphoblastic leukemia: TCCSG L99-15 study.
    Hasegawa D; Manabe A; Ohara A; Kikuchi A; Koh K; Kiyokawa N; Fukushima T; Ishida Y; Saito T; Hanada R; Tsuchida M;
    Pediatr Blood Cancer; 2012 Jan; 58(1):23-30. PubMed ID: 21254378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Central nervous system metastases in HER-2 positive metastatic breast cancer patients treated with trastuzumab: incidence, survival, and risk factors.
    Gori S; Rimondini S; De Angelis V; Colozza M; Bisagni G; Moretti G; Sidoni A; Basurto C; Aristei C; Anastasi P; Crinò L
    Oncologist; 2007 Jul; 12(7):766-73. PubMed ID: 17673608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of central nervous system involvement at diagnosis of childhood T-cell acute lymphoblastic leukemia.
    Jaing TH; Yang CP; Hung IJ; Tsay PK; Tseng CK; Chen SH
    Pediatr Blood Cancer; 2005 Aug; 45(2):135-8. PubMed ID: 15704218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
    Sancho JM; Ribera JM; Oriol A; Hernandez-Rivas JM; Rivas C; Bethencourt C; Parody R; Deben G; Bello JL; Feliu E;
    Cancer; 2006 Jun; 106(12):2540-6. PubMed ID: 16700036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Germ-cell tumors of the central nervous system in childhood: retrospective study of 13 patients].
    Voirin J; Klein O; Chastagner P; Moret C; Vignaud JM; Auque J; Marchal JC
    Neurochirurgie; 2008 Apr; 54(2):55-62. PubMed ID: 18355878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Case series: CSF LDH, proteins and electrolyte levels in patients of acute lymphocytic leukemia.
    Rao D; Ghalaut VS; Ghalaut PS; Rao S
    Clin Chim Acta; 2012 Jul; 413(13-14):1045-8. PubMed ID: 22387722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autologous transplantation in multiple myeloma: a GITMO retrospective analysis on 290 patients. Gruppo Italiano Trapianti di Midollo Osseo.
    Majolino I; Vignetti M; Meloni G; Vegna ML; Scimè R; Tringali S; Amaddii G; Coser P; Tribalto M; Raimondi R; Bergonzi C; Sajeva MR; Sica S; Ferrando F; Messina G; Mandelli F
    Haematologica; 1999 Sep; 84(9):844-52. PubMed ID: 10477460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group.
    Hoang-Xuan K; Taillandier L; Chinot O; Soubeyran P; Bogdhan U; Hildebrand J; Frenay M; De Beule N; Delattre JY; Baron B;
    J Clin Oncol; 2003 Jul; 21(14):2726-31. PubMed ID: 12860951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. International prognostic index (IPI)--a critical comparison with five multiple myeloma staging systems in the group of 270 patients treated by conventional chemotherapy.
    Scudla V; Zemanova M; Minarik J; Bacovsky J; Ordeltova M; Indrak K; Budikova M; Dusek L; Farbiakova V
    Neoplasma; 2006; 53(4):277-84. PubMed ID: 16830053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple bulky cutaneous plasmacytomas with CNS relapse without bone marrow involvement during the course of a lambda light chain myeloma.
    Serefhanoglu S; Haznedaroglu IC; Goker H; Buyukasik Y; Ozcebe OI
    Onkologie; 2009 Nov; 32(11):662-4. PubMed ID: 19887870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors.
    Kim A; Ji L; Balmaceda C; Diez B; Kellie SJ; Dunkel IJ; Gardner SL; Sposto R; Finlay JL
    Pediatr Blood Cancer; 2008 Dec; 51(6):768-73. PubMed ID: 18802946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma.
    Bierman P; Giglio P
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):597-609, v. PubMed ID: 16083825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benefit of ventriculoperitoneal cerebrospinal fluid shunting and intrathecal chemotherapy in neoplastic meningitis: a retrospective, case-controlled study.
    Lin N; Dunn IF; Glantz M; Allison DL; Jensen R; Johnson MD; Friedlander RM; Kesari S
    J Neurosurg; 2011 Oct; 115(4):730-6. PubMed ID: 21721878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.